Post-COVID mucormycosis: A retrospective observational study

Post-COVID mucormycosis: A retrospective observational study

Introduction: Mucormycosis is a life-threatening fungal infection caused by fungi belonging to the family Mucorales, and the fungus mainly responsible for infection in humans is Rhizopus oryzae. Recently, several cases of coronavirus disease 2019 (COVID-19)-associated mucormycosis are being reported...

Full description

Bibliographic Details
Main Authors:	Nurani Shaik, Akhila Bollam, Gayathri Konduri, Aedula Vinaya Sekhar
Format:	Article
Language:	English
Published:	Jaypee Brothers Medical Publisher 2022-01-01
Series:	Indian Journal of Respiratory Care
Subjects:	amphotericin b covid diabetes mellitus posaconazole postcoronavirus disease 2019 mucormycosis
Online Access:	http://www.ijrc.in/article.asp?issn=2277-9019;year=2022;volume=11;issue=3;spage=230;epage=233;aulast=Shaik

Similar Items

Efficacy of combination therapy of amphotericin and posaconazole in treatment of mucormycosis
by: Sridhara S, et al.
Published: (2023-03-01)

Silent choker: Unveiling tracheal stenosis as an atypical manifestation of mucormycosis
by: Mehul G Kaliya, et al.
Published: (2024-01-01)

Posaconazole as single or adjunctive antifungal in mucormycosis of the maxilla: systematic review and meta-analysis
by: Pardiwala Arwa, et al.
Published: (2023-01-01)

A rare case of pulmonary mucormycosis complicated by hydropneumothorax, successfully treated with non‐surgical therapies
by: Qiliang Liu, et al.
Published: (2022-06-01)

Successful treatment of pulmonary mucormycosis in a child with aplastic anemia
by: Ye. A. Nikitina, et al.
Published: (2014-07-01)

Successful treatment of pulmonary mucormycosis in a child with aplastic anemia
by: Ye. A. Nikitina, et al.
Published: (2014-07-01)

An unusual ulcer: A case of cutaneous mucormycosis caused by Rhizopus oryzae
by: Bradley J. Gardiner, et al.
Published: (2015-03-01)

The successful use of amphotericin B followed by oral posaconazole in a rare case of invasive fungal sinusitis caused by co-infection with mucormycosis and aspergillus
by: Sharana Mahomed, et al.
Published: (2015-01-01)

Mucormycosis in a Severe Trauma Patient Treated with a Combination of Systemic Posaconazole and Topical Amphotericin B—Case Report
by: Filip Keller, et al.
Published: (2023-09-01)

Mucormycosis and aspergillosis: The deadly duo in COVID-19—a case report
by: Bijaya Mohanty, et al.
Published: (2022-01-01)

Disseminated pulmonary mucormycosis with concomitant tuberculosis infection in a diabetic patient
by: Priyamvadha Ramesh, et al.
Published: (2020-01-01)

Intestinal mucormycosis in an adult with H1N1 pneumonia on extracorporeal membrane oxygenation
by: G J Himaal Dev, et al.
Published: (2021-01-01)

Therapy of Mucormycosis
by: Nikolaos V. Sipsas, et al.
Published: (2018-07-01)

A study of mucormycosis in second wave of COVID-19
by: H.T. Lathadevi, et al.
Published: (2024-04-01)

Disseminated Saksenaea infection in an immunocompromised host associated with a good clinical outcome: a case report and review of the literature
by: N. Davidson, et al.
Published: (2020-10-01)

Rhinomaxillary Mucormycosis with Palatal Perforation: A Case Report
by: Sreenath G, et al.
Published: (2014-09-01)

Clinical and Paraclinical Survey of Hospitalised Cases of Mucormycosis in Two Centres in Ghaemshahr and Sari during 2011-2018
by: Lotfollah Davoodi, et al.
Published: (2023-11-01)

Epidemiology of Mucormycosis in India
by: Hariprasath Prakash, et al.
Published: (2021-03-01)

Invasive rhino-orbito-cerebral mucormycosis in a diabetic patient – the need for prompt treatment
by: Vanessa Chow, et al.
Published: (2015-06-01)

COVID-19 and rhino-orbital mucormycosis – A case report
by: Dilbag Singh, et al.
Published: (2023-01-01)

Epidemiology and management of mucormycosis in India – Pre- and Post-COVID-19
by: Nandini Sethuraman
Published: (2021-01-01)

Mucormycosis: modern diagnostics and treatment, existing problems and new trends in antifungal therapy
by: Popova M.O., et al.
Published: (2021-09-01)

Rhino–Orbito–Cerebral Mucormycosis Resistant to Amphotericin B: Two Diabetic Cases
by: Esma Eren, et al.
Published: (2019-09-01)

Mucormycosis: A 14-Year Retrospective Study from a Tertiary Care Center in Lebanon
by: Fatima Allaw, et al.
Published: (2023-08-01)

COVID-19-associated mucormycosis: Preliminary report from a tertiary eye care centre
by: Shweta Walia, et al.
Published: (2021-01-01)

Isolated Involvement of Palatine Tonsil by COVID-19–Associated Mucormycosis
by: Santosh Kumar Swain
Published: (2022-01-01)

Mucormycosis: A diagnostic and therapeutic challenge: A Case Report
by: D. Wickramasinghe, et al.
Published: (2021-10-01)

Clinical manifestations and management of ocular mucormycosis during COVID-19 pandemic in Eastern India: A retrospective analysis
by: Swati Samant, et al.
Published: (2023-01-01)

Post COVID-19 mucormycosis: A case series
by: Mala Vinod Kaneria, et al.
Published: (2021-01-01)

Mucormycosis
by: S. D. Mathebula
Published: (2008-12-01)

Clinical Presentation and Outcome of Sinonasal Mucormycosis in Pre COVID-19 Era from a Tertiary Care Centre in Uttarakhand: A Cross-sectional Study
by: Vinish Kumar Agarwal, et al.
Published: (2022-07-01)

The impact of SARS-CoV-2 on the sudden onset of Mucormycosis in the Indian subcontinent-A review
by: Shakila Mahesh, et al.
Published: (2022-01-01)

Mucormycosis: Effect of Comorbidities and Repeated Debridement on the Outcome
by: Harshavardhan N Reddy, et al.
Published: (2019-04-01)

Mucormycosis: Effect of Comorbidities and Repeated Debridement on the Outcome
by: Harshavardhan N Reddy, et al.
Published: (2019-04-01)

Mucormycosis associated with juvenile diabetes
by: SVSG Nirmala, et al.
Published: (2011-01-01)

Isolated splenic mucormycosis secondary to diabetic ketoacidosis: a case report
by: Shuai Luo, et al.
Published: (2022-07-01)

The Role of Retrobulbar Injection of Amphotericin B in the Management of Orbital Mucormycosis in a Tertiary Care Centre—Prospective Analytical Study
by: A Yogeswari, et al.
Published: (2023-01-01)

A sinister call for the dermatologist from intensive care unit: Mucormycosis revisited
by: Vikas Pathania, et al.
Published: (2022-01-01)

Isolated renal mucormycosis in children: A case report and review of the literature
by: Sachit Anand, et al.
Published: (2021-01-01)

Coronavirus disease 2019-associated mucormycosis of the head-and-neck area: A new rise of dreaded black fungus in the current pandemic
by: Santosh Kumar Swain, et al.
Published: (2022-01-01)